Paolo Fundaro Net Worth & Insider Trades
Paolo Fundaro - Director, Intercept Pharmaceuticals, Inc
What is Paolo Fundaro's Net Worth?
The current estimated net worth of Intercept Pharmaceuticals, Inc's Director, Paolo Fundaro, is estimated to be about $188.1M . Paolo Fundaro owns about 4,021,028 units of Intercept Pharmaceuticals, Inc common stock. In the last 11 years at Intercept Pharmaceuticals, Inc, Paolo Fundaro has sold an estimated value of $125.13M worth.
What is Paolo Fundaro's Past Insider Trading?
Paolo Fundaro's largest purchase order was 6,922 units , worth over $59.99K on February 14, 2014. Paolo Fundaro's largest sale order was 1,500,000 units , worth over $71.25M on August 17, 2020. In total, Paolo Fundaro has made about 25 transactions over 11 years of their time at Intercept Pharmaceuticals, Inc. Paolo Fundaro usually trades in May, with the busiest year in 2014.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Paolo Fundaro
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Paolo Fundaro's' Mailing Address?
- Mailing address is C/o Genextra S.P.A., Via G. de Grassi, 11 Milan L6 20123 Italy
Intercept Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Mark Pruzanski, M.D., | 2020 | $757,850 | - | $4,113,504 | $1,015,996 | $531,995 | $7,660 | $6,427,005 |
| Mark Pruzanski, M.D., | 2019 | $734,292 | - | $4,197,742 | $1,116,118 | $560,265 | $7,368 | $6,615,785 |
| Mark Pruzanski, M.D., | 2018 | $702,000 | - | $1,667,718 | $1,705,358 | $442,260 | $8,623 | $4,525,960 |
| Jerome Durso, | 2020 | $599,524 | - | $2,057,016 | $998,776 | $231,737 | $21,910 | $3,908,963 |
| Jerome Durso, | 2019 | $573,250 | - | $2,089,570 | $1,238,321 | $359,284 | $21,368 | $4,281,793 |
| Jerome Durso, | 2018 | $540,800 | - | $1,554,326 | $775,844 | $292,032 | $22,403 | $3,185,406 |
| Sandip Kapadia, | 2020 | $476,863 | - | $1,087,836 | $528,088 | $184,039 | $21,910 | $2,298,736 |
| Sandip Kapadia, | 2019 | $464,100 | - | $1,001,664 | $586,573 | $252,935 | $21,368 | $2,326,640 |
| Sandip Kapadia, | 2018 | $442,000 | - | $790,164 | $393,544 | $228,735 | $22,403 | $1,876,846 |
| Richard Kim, | 2020 | $456,095 | - | $1,044,360 | $505,128 | $168,056 | $79,211 | $2,252,850 |
| Richard Kim, | 2019 | $442,900 | $202,800 | $890,368 | $521,398 | $265,519 | $76,343 | $2,399,328 |
| Lisa Bright, | 2020 | $480,552 | - | $925,704 | $453,467 | $240,955 | $139,106 | $2,239,784 |
| Ryan Sullivan, | 2020 | $437,107 | - | $1,087,836 | $528,088 | - | $89,942 | $2,142,973 |
| Ryan Sullivan, | 2019 | $445,520 | - | $1,471,902 | $871,713 | $267,089 | $21,368 | $3,077,592 |
| Ryan Sullivan, | 2018 | $376,158 | - | $1,239,112 | $1,190,351 | $229,122 | $173,437 | $3,208,180 |
| Christian Weyer, M.D., M.A.S., | 2020 | $486,731 | - | $925,704 | $453,467 | $170,804 | $21,910 | $2,058,616 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1270073/000110465921055639/tm218121-2_def14a.htm
What are Intercept Pharmaceuticals, Inc's Past Insider Trades?
Intercept Pharmaceuticals, Inc's most recent insider trade came on March 12, 2021 by Srinivas Akkaraju who bought 237,000 units worth $5.02M . In the last 9 years, insiders at Intercept Pharmaceuticals, Inc have sold an estimated value of $1.66B and bought an estimated value of $148.73M worth of shares. Insider trading is most common in January, with the busiest year in 2019. The most active traders at the company are David Shapiro, Chief Medical Officer, Mark Pruzanski, Director, and Lisa Bright, President .
INTERCEPT PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||